Brensocatib
Drug Details
- Generic Name
- Brensocatib
- Brand Names
- Brinsupri
- Application Number
- NDA217673
- Sponsor
- Insmed Incorporated
- NDC Codes
- 2
- Dosage Forms
- TABLET
- Routes
- ORAL
- Active Ingredients
- BRENSOCATIB
Indications and Usage
1 INDICATIONS AND USAGE BRINSUPRI is indicated for the treatment of non-cystic fibrosis bronchiectasis (NCFB) in adult and pediatric patients 12 years of age and older. BRINSUPRI is a dipeptidyl peptidase 1 (DPP1) inhibitor indicated for the treatment of non-cystic fibrosis bronchiectasis in adult and pediatric patients 12 years of age and older. ( 1 )